CR9425A - Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo - Google Patents
Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismoInfo
- Publication number
- CR9425A CR9425A CR9425A CR9425A CR9425A CR 9425 A CR9425 A CR 9425A CR 9425 A CR9425 A CR 9425A CR 9425 A CR9425 A CR 9425A CR 9425 A CR9425 A CR 9425A
- Authority
- CR
- Costa Rica
- Prior art keywords
- association
- treatment
- paludism
- railway
- ferroquine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La invencion tiene por objeto una asociacion que comprende ferroquina, en forma de base libre, de sal, de hidrato o de solvato y un derivado de artemisinina. La invencion tiene tambien por objeto una composicion farmaceutica que comprende ferroquina, en forma de una de sus sales farmaceuticamente aceptables, de un hidrato o de un solvato de la ferroquina, y de al menos un derivado de artemisinina. La invencion tiene tambien por objeto la utilizacion de tal asociacion para la preparacion de un medicamento destinado al tratamiento o a la prevencion del paludismo. La invencion tiene por ultimo por objeto un kit para el tratamiento o la prevencion del paludismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0503932A FR2884715B1 (fr) | 2005-04-20 | 2005-04-20 | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9425A true CR9425A (es) | 2008-02-20 |
Family
ID=35385843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9425A CR9425A (es) | 2005-04-20 | 2007-10-08 | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20120258945A1 (es) |
| EP (1) | EP1874293A1 (es) |
| JP (1) | JP5148478B2 (es) |
| KR (1) | KR20080009088A (es) |
| CN (2) | CN101163470A (es) |
| AP (1) | AP2782A (es) |
| AR (1) | AR054253A1 (es) |
| AU (1) | AU2006238506B2 (es) |
| BR (1) | BRPI0610851A2 (es) |
| CA (1) | CA2605385A1 (es) |
| CR (1) | CR9425A (es) |
| DO (1) | DOP2006000092A (es) |
| EA (1) | EA012630B1 (es) |
| FR (1) | FR2884715B1 (es) |
| GT (1) | GT200600157A (es) |
| HN (1) | HN2006015130A (es) |
| IL (1) | IL186048A0 (es) |
| MA (1) | MA29451B1 (es) |
| MX (1) | MX2007012645A (es) |
| MY (1) | MY145581A (es) |
| NO (1) | NO20075920L (es) |
| NZ (1) | NZ562117A (es) |
| PA (1) | PA8669801A1 (es) |
| PE (2) | PE20061314A1 (es) |
| SG (1) | SG161270A1 (es) |
| TN (1) | TNSN07359A1 (es) |
| TW (1) | TWI387456B (es) |
| UA (1) | UA96414C2 (es) |
| WO (1) | WO2006111647A1 (es) |
| ZA (1) | ZA200708800B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2926993B1 (fr) * | 2008-02-06 | 2011-03-11 | Sanofi Aventis | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
| FR2952823B1 (fr) * | 2009-10-30 | 2012-04-20 | Sanofi Aventis | Utilisation de la ferroquine dans le traitement ou la prevention du paludisme |
| FR2951945B1 (fr) * | 2009-11-05 | 2013-08-09 | Sanofi Aventis | Composition pharmaceutique |
| FR2961209B1 (fr) * | 2010-06-11 | 2013-03-01 | Sanofi Aventis | Procede de synthese de la ferroquine par amination reductrice convergente. |
| FR2989588A1 (fr) * | 2012-04-19 | 2013-10-25 | Centre Nat Rech Scient | Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae |
| JP6806563B2 (ja) | 2013-11-08 | 2021-01-06 | エクステラ・メディカル・コーポレーション | 吸着媒体を使用する感染症の診断法 |
| CN105250295B (zh) * | 2014-07-07 | 2018-12-25 | 广州中医药大学科技产业园有限公司 | 一种联合用药物及其作为免疫调节剂的应用 |
| WO2017015344A1 (en) * | 2015-07-20 | 2017-01-26 | University Of Vermont And State Agricultural College | Use of cymanquine compounds as antimalarial agents |
| CN107802755A (zh) * | 2017-11-08 | 2018-03-16 | 江西龙卿堂科技有限公司 | 一种具有防蚊防疟作用的青蒿软膏 |
| KR102073961B1 (ko) * | 2018-11-16 | 2020-02-05 | (주)프론트바이오 | 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 |
| WO2022231238A1 (ko) * | 2021-04-26 | 2022-11-03 | 심민보 | 아르테수네이트 또는 그의 염, 및 피로나리딘 또는 그의 염의 해열, 항염증, 항바이러스용, 또는 covid-19 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법 |
| CN113952360B (zh) * | 2021-09-14 | 2023-03-10 | 上海交通大学 | 一种亚铁离子在治疗疟疾的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN166154B (es) * | 1987-05-08 | 1990-03-24 | Hoechst India | |
| AP2006003557A0 (en) * | 2003-09-04 | 2006-04-30 | Cipla Ltd | Antimalarial compositions and process thereof. |
-
2005
- 2005-04-20 FR FR0503932A patent/FR2884715B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-17 PE PE2006000399A patent/PE20061314A1/es not_active Application Discontinuation
- 2006-04-17 PE PE2010000537A patent/PE20110119A1/es not_active Application Discontinuation
- 2006-04-18 NZ NZ562117A patent/NZ562117A/en not_active IP Right Cessation
- 2006-04-18 UA UAA200712809A patent/UA96414C2/ru unknown
- 2006-04-18 AU AU2006238506A patent/AU2006238506B2/en not_active Ceased
- 2006-04-18 BR BRPI0610851-2A patent/BRPI0610851A2/pt not_active IP Right Cessation
- 2006-04-18 MX MX2007012645A patent/MX2007012645A/es active IP Right Grant
- 2006-04-18 JP JP2008507122A patent/JP5148478B2/ja not_active Expired - Fee Related
- 2006-04-18 CN CNA2006800130136A patent/CN101163470A/zh active Pending
- 2006-04-18 SG SG201002562-5A patent/SG161270A1/en unknown
- 2006-04-18 CN CN201210369240XA patent/CN102836163A/zh active Pending
- 2006-04-18 ZA ZA200708800A patent/ZA200708800B/xx unknown
- 2006-04-18 EA EA200702282A patent/EA012630B1/ru not_active IP Right Cessation
- 2006-04-18 MY MYPI20061772A patent/MY145581A/en unknown
- 2006-04-18 KR KR1020077024076A patent/KR20080009088A/ko active IP Right Grant
- 2006-04-18 CA CA002605385A patent/CA2605385A1/fr not_active Abandoned
- 2006-04-18 EP EP06743711A patent/EP1874293A1/fr not_active Withdrawn
- 2006-04-18 WO PCT/FR2006/000842 patent/WO2006111647A1/fr active Application Filing
- 2006-04-18 AP AP2007004211A patent/AP2782A/xx active
- 2006-04-19 AR AR20060101538A patent/AR054253A1/es unknown
- 2006-04-19 PA PA20068669801A patent/PA8669801A1/es unknown
- 2006-04-20 HN HN2006015130A patent/HN2006015130A/es unknown
- 2006-04-20 TW TW095114167A patent/TWI387456B/zh not_active IP Right Cessation
- 2006-04-20 DO DO2006000092A patent/DOP2006000092A/es unknown
- 2006-04-20 GT GT200600157A patent/GT200600157A/es unknown
-
2007
- 2007-09-18 IL IL186048A patent/IL186048A0/en unknown
- 2007-09-21 TN TNP2007000359A patent/TNSN07359A1/en unknown
- 2007-10-08 CR CR9425A patent/CR9425A/es unknown
- 2007-10-18 US US11/874,377 patent/US20120258945A1/en not_active Abandoned
- 2007-11-16 NO NO20075920A patent/NO20075920L/no not_active Application Discontinuation
- 2007-11-19 MA MA30375A patent/MA29451B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR9425A (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
| ECSP066950A (es) | Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2 | |
| UY30460A1 (es) | Compuestos terapéuticos | |
| CR8569A (es) | Inhibidores de integrasa de vih | |
| ECSP088296A (es) | Compuestos terapéuticos | |
| CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
| CL2008003284A1 (es) | Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras. | |
| HRP20080313A2 (en) | Methods for improving the pharmacokinetics of hiv integrase inhibitors | |
| CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
| CL2011000798A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| DOP2012000050A (es) | Nuevas composiciones de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil] piperazina | |
| CL2011000806A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| CR9737A (es) | Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) sus sales. | |
| CO6531485A2 (es) | Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa | |
| CR20190144A (es) | Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos | |
| CL2011002233A1 (es) | Metodo para tratar o prevenir el cancer, que comprende administrar una combinacion farmaceutica sinergica de: a) (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopropan-1-sulfonamida y b) 3-(6,7-bis(2-metoxietoxi)quinazolin-4-ilamino)benzonitrilo; composicion farmaceutica; y kit farmaceutico. | |
| CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
| PA8571901A1 (es) | Nueva composicion farmaceutica | |
| CR20190145A (es) | Compuestos de indazol para usar en lesiones de tendones y/o ligamentos | |
| ECSP10010381A (es) | Asociacion entre una sal de bis-tiazolio o uno de sus precursores y artemisinina o uno de sus derivados para el tratamiento del paludismo grave | |
| PA8789101A1 (es) | Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble | |
| UY29488A1 (es) | Asociación entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
| AR067498A1 (es) | Composicion farmaceutica estable de una sal hidrosoluble de vinorrelbina | |
| PE20071158A1 (es) | Composicion farmaceutica que comprende una asociacion entre ferroquina y un derivado de artemisinina | |
| CR20140109S (es) | Composiciones farmaceuticas estabilizadoras que comprenden fesoterodina |